Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00547768 |
Compare the effect of a single dose of fexofenadine HCl 180 mg plus orange juice versus placebo plus orange juice on the change from baseline (pre-dose) in histamine skin flares.
Condition | Intervention | Phase |
---|---|---|
Allergy |
Drug: Fexofenadine HCI |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Crossover Assignment |
Enrollment: | 36 |
Study Start Date: | November 2002 |
Study Completion Date: | December 2002 |
Ages Eligible for Study: | 12 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | M016455A/4144 |
Study First Received: | October 22, 2007 |
Last Updated: | November 8, 2007 |
ClinicalTrials.gov Identifier: | NCT00547768 History of Changes |
Health Authority: | United States: Institutional Review Board |
Neurotransmitter Agents Hypersensitivity Histamine Antagonists Fexofenadine |
Histamine phosphate Histamine H1 Antagonists Anti-Allergic Agents Histamine |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Histamine Antagonists Therapeutic Uses Physiological Effects of Drugs Fexofenadine |
Histamine Agents Histamine H1 Antagonists Anti-Allergic Agents Histamine H1 Antagonists, Non-Sedating Pharmacologic Actions |